Insurance status may affect cancer outcome

In In The News by Barbara Jacoby

By Randy Dotinga From: usnews.com A new U.S. study finds that cancer patients who don’t have insurance — or who get it through the federal health insurance program for the poor (Medicaid) — are at much higher risk of poor medical outcomes than other people. They’re more likely to have advanced cancer when they’re diagnosed, less likely to be treated …

Salt injection ‘kills cancer cells’

In In The News by Barbara Jacoby

By Press Association From: dailymail.co.uk Scientists have created a technique which can cause cancer cells to self-destruct by injecting them with salt. Researchers from the University of Southampton are part of an international team that has helped to create a molecule that can cause cancer cells to die by carrying sodium and chloride ions into the cells. Synthetic ion transporters …

La, Miss hospitals form cancer drug test network

In In The News by Barbara Jacoby

By: JANET McCONNAUGHEY From: theadvocate.com Cancer patients in Louisiana and south Mississippi will find it easier to join tests of treatments and promising new drugs under a network organized by the LSU cancer centers in New Orleans and Shreveport. Officials say including local hospitals and clinics will reduce the need for patients to travel, likely increasing the number who can …

New cancer classification system shows promise as lifesaver

In In The News by Barbara Jacoby

By: Victoria Colliver From: sfgate.com Classifying cancer tumors by their molecular structure rather than the tissue or organ where they were found, such as the breast or bladder, may lead to more accurate diagnoses and potentially better treatments and outcomes for patients, a new study finds. In the largest undertaking to analyze and compare different cancer types based on genomic sequencing, …

Cynvenio launches breast cancer Therapy Finder powered by CollabRx

In In The News by Barbara Jacoby

Cynvenio, a cancer diagnostics company focused on transforming cancer treatment and management through the genomic analysis of tumor cells in the bloodstream, announced Therapy Finder™, a web-based cancer decision support application powered by CollabRx, Inc. [NASDAQ: CLRX]. Available as a reporting option with Cynvenio’s ClearID™ genomic test, Therapy Finder will provide breast cancer patients and their physicians with a dynamic …

FDA To Regulate Thousands Of Cancer, Genetic, And Other Diagnostics

In In The News by Barbara Jacoby

By: Matthew Herper From: forbes.com The Food and Drug Administration unveiled plans to regulate thousands of diagnostic tests, including many coming from the exploding field of genetic research, to which it has until now turned a blind eye. More than 11,000 of these tests, known as laboratory-developed tests, created by 2,000 different laboratories, could be included in the new regulatory …

When Money Motivates Cancer Treatment Options

In In The News by Barbara Jacoby

By: Robert Pearl, M.D. From: forbes.com Today’s article follows the money trail to expose a different form of bias: the kind that takes place when doctors own their own diagnostic and therapeutic equipment. For people living with cancer, this kind of bias can have a particularly painful impact. Radiation Therapy Brings Out Medical Bias In the United States, cancer is …

Cancer Patients Can Get ‘Chemo Brain’; Treatment Available

In In The News by Barbara Jacoby

By Dr. Mallika Marshall From: cbslocal.com Sixty-nine-year-old Susan Harden began her battle with breast cancer six years ago. “I had surgery,” explains Susan, “And that was followed by two different rounds of chemotherapy, followed by radiation.” Soon after her first round of chemo, Susan became confused. The former science teacher, quick-witted all her life, all of a sudden couldn’t remember …

Chemical in foam cups again seen as likely cancer cause

In In The News by Barbara Jacoby

By: Delthia Ricks From: philly.com The National Research Council Monday reaffirmed that styrene — the key chemical component of foam cups and other food service items — might cause cancer in people. A panel of 10 experts in medicine, chemistry and toxicology used a rather stilted definition, “reasonably anticipated to be a human carcinogen,” to uphold the same finding from …